Literature DB >> 21899050

[Preparation and characterization of monoclonal antibodies to Bacillus anthracis protective antigen].

N V Rudenko, S G Abbasova, E V Grishin.   

Abstract

Anthrax is the widespread acute infection disease, affecting animals and humans, refers to the bioterrorist threat agents of category A, because of the high resistance of Bacillus anthracis spores to adverse environmental factors and the ease of receiving them. We obtain a representative panel of 20 monoclonal antibodies against the key component of pathogenic exotoxins, anthrax protective antigen. Quantitative sandwich-ELISA for protective antigen with antibody obtained was developed. Six pairs of monoclonal antibodies showed the detection limit up to 1 ng/ml concentration of the protective antigen in blood serum.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899050     DOI: 10.1134/s1068162011030162

Source DB:  PubMed          Journal:  Bioorg Khim        ISSN: 0132-3423


  3 in total

1.  Dual-Readout Sandwich Immunoassay for Device-Free and Highly Sensitive Anthrax Biomarker Detection.

Authors:  Isaac N Larkin; Viswanadham Garimella; Gokay Yamankurt; Alexander W Scott; Hang Xing; Chad A Mirkin
Journal:  Anal Chem       Date:  2020-05-21       Impact factor: 6.986

2.  High expression of 23 kDa protein of augmenter of liver regeneration (ALR) in human hepatocellular carcinoma.

Authors:  Hai-Ying Yu; Man-Hua Zhu; Dai-Rong Xiang; Jun Li; Ji-Fang Sheng
Journal:  Onco Targets Ther       Date:  2014-06-02       Impact factor: 4.147

3.  Immunochemical assay with monoclonal antibodies for detection of staphylococcal enterotoxin H.

Authors:  Natalia Vasilyevna Rudenko; Anna Petrovna Karatovskaya; Anatolyi Nikolaevich Noskov; Anna Olegovna Shepelyakovskaya; Margarita Pavlovna Shchannikova; Irina Vladimirovna Loskutova; Olga Anatolievna Artyemieva; Daria Alexandrovna Nikanova; Elena Alexandrovna Gladyr; Fedor Alexandrovich Brovko
Journal:  J Food Drug Anal       Date:  2017-12-02       Impact factor: 6.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.